Nelson Wohllk
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Genotype-specific neoplastic risk profiles in patients with VHL disease.
Journal: Endocrine-related cancer
Published: October 08, 2024
Beyond the Recommendations of the Clinical Guidelines for Medullary Thyroid Cancer - A Case Report.
Journal: Revista medica de Chile
Published: December 22, 2022
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.
Journal: Endocrine connections
Published: April 16, 2020
A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 08, 2020
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.
Journal: JAMA network open
Published: August 10, 2019
Prognostic value of granular pattern of growth hormone secreting tumors
Journal: Revista medica de Chile
Published: December 04, 2018
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
Journal: The lancet. Diabetes & endocrinology
Published: October 19, 2018
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: April 24, 2018
The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations.
Journal: Endocrine-related cancer
Published: May 22, 2017
A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 20, 2017
Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness".
Journal: The Journal of clinical endocrinology and metabolism
Published: May 18, 2017
Last Updated: 09/26/2026